AlphaMaven AlphaMaven

Greenoaks, Sequoia lead $5bn Series C for AI drug developer Isomorphic Labs

Reported by Alternatives Watch
Nov 19, 2026· 3 min read
Save Post LinkedIn Email
Greenoaks and Sequoia co-led a $5 billion Series C for AI drug developer Isomorphic Labs, lifting its venture funding to $7.7 billion across three rounds.
Read Full Article

Want more insights?

An AlphaMaven membership unlocks every executive summary, the full screener, and 127.5K+ alternative investment headlines — from $99/mo.

Start researching — $99/mo

Sources

1 outlet

AlphaMaven summarised this story from the reporting below. Each link opens the original article.

Alternatives Watch Greenoaks, Sequoia lead $5bn Series C for AI drug developer Isomorphic Labs